FDA Inspection 664260 — Travanti Pharma, Inc.
The FDA completed an inspection of Travanti Pharma, Inc. on May 13, 2010 in Mendota Heights, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 13, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mendota Heights, MN (United States)
Additional Details
Sponsor, Contract Research Organization